Avid Bioservices (CDMO) Tops Q4 EPS by 12c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St slips as higher yields and oil prices flag inflation risk
- Oil jumps as Middle East supply concerns persist amid shipping attacks
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
- Lynx sees AI semiconductor rally extending into year-end
- Anthropic launches Claude Haiku 5.5 with tiered pricing structure
- Sportradar to sell Synergy Sports coaching unit for $170M
- Rezolve AI (RZLV) Reiterated at Overweight by Cantor Fitzgerald on Positioning as Key Component in E-Commerce Stack
- Wall Street ends lower, off record highs, as Treasury yields climb
- Oracle and these 6 stocks are newest addition to Mizuho Top Picks list
Avid Bioservices (CDMO) PT Raised to $6 at H.C. Wainwright
July 17, 2018 10:22 AM EDTH.C. Wainwright raised its price target on Avid Bioservices (NASDAQ: CDMO) to $6.00 (from $5.00) while maintaining a Buy rating.
Analyst Joseph Pantginis commented, "Yesterday, CDMO reported F4Q18 and FY18 ended April 30, 2018, posting EPS of $0.03 and ($0.56), respectively, compared with our estimate of ($0.23) and ($0.87) and consensus of ($0.15) and... More



